A weed killer sprayed across farmland and roadsides for decades just earned a new flag in colon cancer research.
Quick Take
- A new Nature Medicine study links a chemical marker for the herbicide picloram to early-onset colorectal cancer in adults under 50.
- Researchers compared DNA changes in younger and older cancer patients using data from multiple cancer centers worldwide.
- A separate Nature study found a childhood bacteria exposure leaves a fingerprint in tumors tied to younger cancer cases.
- Doctors say no single chemical or germ fully explains why colon cancer keeps rising in people under 50.
A Pesticide Marker Shows Up In Younger Colon Cancer Patients
Scientists studying early-onset colorectal cancer found something new hiding in patients’ DNA. Their study, published in Nature Medicine, flagged a chemical signature tied to picloram, a common herbicide used on crops, pastures, and roadside weeds. The signal showed up again and again across different groups of patients, which gave researchers more confidence it was not a fluke.
The herbicide connection caught the attention of digestive health specialists almost immediately. A summary from the American Society for Gastrointestinal Endoscopy highlighted the picloram finding as a notable new lead in understanding why colon cancer keeps showing up in younger patients who have none of the usual risk factors like family history or obesity.
How Researchers Spotted The Pattern
The team did not test patients’ blood for pesticide residue directly. Instead, they looked at DNA methylation, which are chemical tags on genes that shift based on what a person has been exposed to over their life. They built a scoring system for different exposures, then compared those scores between early-onset and late-onset colon cancer patients using genetic data from The Cancer Genome Atlas plus nine other patient groups.
That approach let scientists test many possible exposures at once, including diet, smoking, and various chemicals, instead of guessing at just one culprit. Picloram stood out because the pattern held up in a second, independent check using fresh data. Federal officials have already acknowledged that pesticide use is one of the environmental factors worth investigating in rising young-adult cancer cases.
A Second Suspect: Bacteria Exposure In Early Childhood
Pesticides are not the only theory on the table. Researchers from a separate Nature study sequenced nearly 1,000 colon cancer tumors from patients in eleven countries. They found a distinct mutation pattern linked to colibactin, a toxin made by certain gut bacteria, and it showed up more often in tumors from younger patients.
The theory holds that exposure to this bacteria early in childhood may leave a lasting mark on colon cells, one that slowly builds toward cancer decades later. It is a different mechanism than a chemical exposure, but it points to the same basic idea. Something in the environment or in early life is shaping these cancers long before diagnosis.
Why Doctors Won’t Blame Just One Thing
Colon cancer in adults under 50 has been climbing for years, and researchers have struggled to pin down why. A review of the medical literature lists pesticides, air pollution, microplastics, and chemical food additives as candidate explanations, alongside diet and obesity, without settling on one dominant cause. That list keeps growing rather than narrowing.
Clinicians treating these younger patients say the incidence rate is expected to roughly double by 2030 compared to 2010 levels, which adds urgency to figuring out the cause. Until researchers can trace individual exposure histories alongside tumor DNA, the picloram and colibactin findings will stand as strong leads rather than confirmed causes. That distinction matters, but it does not make the signals any less worth taking seriously.
For now, the practical takeaway is straightforward. Colon cancer screening guidelines already start at age 45 because of this trend, and younger adults with persistent digestive symptoms should not assume they are too young for the disease. The science behind why rates are rising is still catching up, but the warning signs deserve attention regardless of the final answer.
Sources:
mindbodygreen.com, nature.com, sanger.ac.uk, ecancer.org, cancer.gov, asge.org
